Current and Former Awardees

Accelerating Cancer Cures
Omar Abdel-Wahab, MD
"Understanding and targeting altered histone modifiers in the myeloid malignancies" at Memorial Sloan Kettering Cancer Center
Arash Ash Alizadeh, MD, PhD
"Targeting the malignant reprograming of early hematopoietic progenitors to mature aggressive human B-cell lymphomas" at Stanford University School of Medicine
Vivek K. Arora, MD, PhD
"Defining a targetable oncogenic dyad in bladder cancer" at Washington University
Vinod P. Balachandran, MD
"Defining the evolutionary dynamics and antigen potential of neoantigens for human pancreatic cancer immunotherapy" at Memorial Sloan Kettering Cancer Center
Christopher E. Barbieri, MD, PhD
"Presurgical trials to target distinct subclasses of localized prostate cancer" at Weill Cornell Medicine
Oren J. Becher, MD
"Regional differences in central nervous system gliomagenesis" at Northwestern University
Himisha Beltran, MD
"Utilizing genome sequencing to elucidate mechanisms of resistance in advanced prostate cancer" at Weill Medical College of Cornell University
Ami S. Bhatt, MD, PhD
"Applying microbiome-based therapeutics in cancer patients" at Stanford University
Collin M. Blakely, MD, PhD
"Mechanisms of incomplete response and primary resistance to osimertinib in EGFR-mutant lung cancer" at University of California, San Francisco
Marie Bleakley, MD, PhD
"Segregating the GVL effect from GVHD in humans" at Fred Hutchinson Cancer Research Center
Adrienne A. Boire, MD, PhD
"Molecular determinants of leptomeningeal metastasis: a translational approach" at Memorial Sloan Kettering Cancer Center
Priscilla K. Brastianos, MD
"Investigation of novel targeted therapeutic approaches for brain metastases" at Massachusetts General Hospital
Joshua Brody, MD
"Flt3L-primed 'in situ' vaccination for low-grade lymphoma - Phase I/II study of intratumoral injection of rhuFlt3L and poly-ICLC with low-dose radiotherapy [NCT01976585]" at Icahn School of Medicine at Mount Sinai
L. Elizabeth Budde, MD, PhD
"Targeting CD123 using chimeric antigen receptor T cells for treatment of acute myeloid leukemia" at City of Hope
Brian C. Capell, MD, PhD
"Defining the role of epigenetic enhancer dysfunction in epithelial carcinogenesis" at University of Pennsylvania, Philadelphia
Sarat Chandarlapaty, MD, PhD
"Therapeutic approaches to PI3K-AKT-mTOR feedback pathways in breast cancer" at Memorial Sloan Kettering Cancer Center
Aude G. Chapuis, MD
"Multifaceted transgenic TCR approach to high-risk AML" at Fred Hutchinson Cancer Research Center
Jaehyuk Choi, MD, PhD
"Identification of genetic basis of altered T cell receptor signaling in cutaneous T cell lymphoma" at Northwestern University
Ryan B. Corcoran, MD, PhD
"Defining novel targeted therapy combination strategies for BRAF V600 mutant colorectal cancer" at Massachusetts General Hospital
Marco L. Davila, MD, PhD
"The development and clinical translation of an armored CAR T cell therapy for immune-resistant B cell malignancies" at H. Lee Moffitt Cancer Center
Gavin P. Dunn, MD, PhD
"Characterizing the immunogenic landscape of glioblastoma" at Washington University
Alejandro Gutierrez, MD
"Mechanisms and therapeutic targeting of EZH2-dependent chemoresistance in T-ALL" at Boston Children's Hospital
Matthew D. Hellmann, MD
"Defining intratumoral and peripheral mechanisms mediating initiation of response, durability, and resistance to PD-1 blockade to inform rational immunotherapeutic development in NSCLC" at Memorial Sloan Kettering Cancer Center
Andrew M. Intlekofer, MD, PhD
"Metabolic coupling of the hypoxic niche to stemness" at Memorial Sloan Kettering Cancer Center
Alex Kentsis, MD, PhD
"Mechanism and function of regulatory signaling in acute myeloid leukemia" at Memorial Sloan Kettering Cancer Center
Christopher A. Klebanoff, MD
"Clinical development of next-generation T cell receptor (TCR)-based adoptive immunotherapies for the treatment of patients with common epithelial malignancies" at Memorial Sloan Kettering Cancer Center
Piro Lito, MD, PhD
"Modeling the evolution of resistance to ERK signaling inhibitors at the single cell level" at Memorial Sloan Kettering Cancer Center
Christine M. Lovly, MD, PhD
"Developing novel therapeutic strategies for ALK-fusion positive lung cancer" at Vanderbilt University
Luc G. Morris, MD
"Functionalizing tumor suppressor gene mutations and deletions in head and neck cancer" at Memorial Sloan Kettering Cancer Center
Ann Mullally, MD
"Determining the role of aberrant growth factor signaling in maintaining disease-propagating cells and mediating JAK2 inhibitor resistance in myeloproliferative neoplasms" at Brigham and Women's Hospital
Deepak Nijhawan, MD, PhD
"Using chemistry to identify new targets in lung cancer" at University of Texas Southwestern Medical Center
Stephen T. Oh, MD, PhD
"Leveraging NFkB pathway dysregulation for therapeutic benefit in myeloproliferative neoplasms" at Washington University
Geoffrey R. Oxnard, MD
"Noninvasive genotyping of cell-free plasma DNA (cfDNA) as a tool for guiding personalized lung cancer care" at Dana-Farber Cancer Institute
Mark G. Shrime, MD, MPH, PhD
"Cash transfers for cancer surgery in West Africa: their health and economic consequences" at Massachusetts Eye and Ear Infirmary
Catherine C. Smith, MD
"Defining structure, function and therapeutic impact of oncogenic FLT3 mutations" at University of California, San Francisco
Zsofia K. Stadler, MD
"Genomic assessment of de novo germline cancer susceptibility in pediatric malignancies" at Memorial Sloan Kettering Cancer Center
Jean Y. Tang, MD, PhD
"Mechanisms of acquired resistance to Hedgehog pathway inhibitors in basal cell carcinomas" at Stanford University
Cameron J. Turtle, MD, PhD
"The impact of the colonic microbiota on reconstitution of CD161hi cells and clinical outcomes after allogeneic hematopoietic stem cell transplantation" at Fred Hutchinson Cancer Research Center
Eliezer M. Van Allen, MD
"Dissecting response to conventional and emerging DNA damage and repair therapies" at Dana-Farber Cancer Institute
Heather L. Yeo, MD
"Use of mobile applications to evaluate post surgical recovery in aging patients with GI cancer" at Weill Cornell Medicine
  • You can support our innovative researchers.